Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach

Cost Effectiveness and Resource Allocation

Volumn 8, Issue , 2010, Pages

  Baeten, Stefan A ^a,b   van Exel, N Job A ^b   Dirks, Maaike ^c   Koopmanschap, Marc A ^b   Dippel, Diederik W J ^c   Niessen, Louis W ^b,d,e  

^a Netherlands Institute for Health Sciences   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INCIDENCE; INTEGRATED HEALTH CARE SYSTEM; LIFE EXPECTANCY; LIFE TABLE METHOD; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PHYSICAL DISABILITY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANKIN SCALE; RISK FACTOR; SCORING SYSTEM; STROKE; SURVIVAL RATE;

EID: 78349249475     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-8-21     Document Type: Article

References (42)

1. Bots ML, Poos MJC. Is the number of stroke patients increasing or decreasing. Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid 2006, Bilthoven: RIVM.
2. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas A-M, Schroll M. Stroke Incidence, Case Fatality, and Mortality in the WHO MONICA Project. Stroke 1995, 26:361-367.
3. Poos MJJC, Smit JM, Groen J, Kommer GJ, Slobbe LCJ. Kosten van ziekten in Nederland 2005: zorg voor euro's. 2008, Bilthoven: RIVM, 8.
4. Struijs JN, van Genugten MLL, Evers SMAA, Ament AJH, Baan CA, van den Bos GAM. Future costs of stroke in the Netherlands: The impact of stroke services. International Journal of Technology Assessment in Health Care 2006, 22:518-524. 10.1017/S0266462306051464, 16984687.
5. Niessen LW, Barendregt JJ, Bonneux L, Koudstaal PJ. Stroke trends in an aging population. The Technology Assessment Methods Project Team. Stroke 1993, 24:931-939.
6. Kalra L, Ratan R. Recent Advances in Stroke Rehabilitation 2006. Stroke 2007, 38:235-237. 10.1161/01.STR.0000254944.91297.a3, 17204671.
7. Langhorne P, Taylor G, Murray G, Dennis M, Anderson C, Bautz-Holter E, Dey P, Indredavik B, Mayo N, Power M, et al. Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. The Lancet 2005, 365:501-506.
8. Norrving B, Adams RJ. Organized Stroke Care. Stroke 2006, 37:326-328. 10.1161/01.STR.0000200554.95094.09, 16410474.
9. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, Selco S, Rajajee V, McNair N, Razinia T, Kidwell CS. In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up. Stroke 2004, 35:2879-2883. 10.1161/01.STR.0000147967.49567.d6, 15514170.
10. Kalra L, Evans A, Perez I, Knapp M, Donaldson N, Swift CG. Alternative strategies for stroke care: a prospective randomised controlled trial. The Lancet 2000, 356:894-899.
11. Moodie M, Cadilhac D, Pearce D, Mihalopoulos C, Carter R, Davis S, Donnan G, for the SSG. Economic Evaluation of Australian Stroke Services: A Prospective, Multicenter Study Comparing Dedicated Stroke Units With Other Care Modalities. Stroke 2006, 37:2790-2795. 10.1161/01.STR.0000245083.97460.e1, 17008615.
12. Patel A, Knapp M, Perez I, Evans A, Kalra L. Alternative Strategies for Stroke Care: Cost-Effectiveness and Cost-Utility Analyses From a Prospective Randomized Controlled Trial. Stroke 2004, 35:196-203. 10.1161/01.STR.0000105390.20430.9F, 14684783.
13. van Exel J, Koopmanschap M, van Wijngaarden J, Scholte op Reimer W. Costs of stroke and stroke services: Determinants of patient costs and a comparison of costs of regular care and care organised in stroke services. Cost Effectiveness and Resource Allocation 2003, 1:2. 10.1186/1478-7547-1-2, 156021, 12773219.
14. van Exel NJA, Koopmanschap MA, Scholte op Reimer W, Niessen LW, Huijsman R. Cost-effectiveness of integrated stroke services. QJM 2005, 98:415-425. 10.1093/qjmed/hci065, 15879443.
15. Saka O, Serra V, Samyshkin Y, McGuire A, Wolfe CCDA. Cost-Effectiveness of Stroke Unit Care Followed by Early Supported Discharge. Stroke 2009, 40:24-29. 10.1161/STROKEAHA.108.518043, 19008473.
16. National Audit Office Progress in improving stroke care. 2010, London: The Stationery Office, Health DO, National Audit Office.
17. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19:604-607.
18. van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. The Lancet 2005, 365:2098-2104.
19. Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P. Is the EuroQol a Valid Measure of Health-Related Quality of Life After Stroke?. Stroke 1997, 28:1876-1882.
20. Lamers LM, Stalmeier PFM, McDonnell J, Krabbe PFM, Van Busschbach JJG. Kwaliteit van leven meten in economische evaluaties: het Nederlands EQ-5D-tarief. Nederlands tijdschrift voor geneeskunde 2005, 149:5.
21. van Exel NJA, Scholte op Reimer WJM, Koopmanschap MA. Assessment of post-stroke quality of life in cost-effectiveness studies: The usefulness of the Barthel Index and the EuroQoL-5D. Quality of Life Research 2004, 13:427-433. 10.1023/B:QURE.0000018496.02968.50, 15085915.
22. Mahoney FI, Barthel DW. Functional Evaluation: The Barthel Index. Md State Med J 1965, 14:61-65.
23. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Standardisation of Costs: The Dutch Manual for Costing in Economic Evaluations. PharmacoEconomics 2002, 20:443-454. 10.2165/00019053-200220070-00002, 12093300.
24. Scholte op Reimer W. Long-term care after stroke. Studies on care utilisation, quality of care and burden of care-giving. 1999, Universtity of Amsterdam, Faculty of Medicine.
25. Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Economics 2007, 16:307-317. 10.1002/hec.1168, 17006970.
26. Stroke Unit Trialists Collaboration Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews 2007, Chichester, UK: John Wiley & Sons, Ltd, Stroke Unit Trialists Collaboration.
27. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations*. The Lancet 1999, 354:1457-1463.
28. Niessen LW, Dippel DW, Limburg M. [Calculation of costs of stroke, cost effectiveness of stroke units and secondary prevention in patients after a stroke, as recommended by revised CBO practice guideline 'Stroke']. Ned Tijdschr Geneeskd 2000, 144:1959-1964.
29. van den Berg B, Brouwer W, van Exel J, Koopmanschap M, van den Bos GAM, Rutten F. Economic valuation of informal care: Lessons from the application of the opportunity costs and proxy good methods. Social Science & Medicine 2006, 62:835-845.
30. Kwa VIH, Limburg M, Haan RJ. The role of cognitive impairment in the quality of life after ischaemic stroke. Journal of Neurology 1996, 243:599-604. 10.1007/BF00900948, 8865027.
31. Falconer JA, Naughton BJ, Strasser DC, Sinacore JM. Stroke inpatient rehabilitation: A comparison across age groups. Journal of the American Geriatrics Society 1994, 42:39-44.
32. Kalra L. Does age affect benefits of stroke unit rehabilitation?. Stroke 1994, 25:346-351.
33. Hack W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K, Leys D, Kwiecinski H, Toni P, Langhorne P. European stroke initiative recommendations for stroke management-update 2003. Cerebrovasc Dis 2003, 16:311-337. 10.1159/000072554, 14584488.
34. Jager-Geurst MH, Peters RJG, van Dis SJ, Bots ML. Hart-en vaatziekten in Nederland, 2006: Cijfers over leefstijl-en risicofactoren, ziekte en sterfte. 2006, The Netherlands Heart Foundation.
35. Statistics Netherlands (CBS) Statline database. 2010, Statistics Netherlands (CBS).
36. Herman B, Leyten AC, van Luijk JH, Frenken CW, Op de Coul AA, Schulte BP. Epidemiology of stroke in Tilburg, the Netherlands. The population-based stroke incidence register: 2. Incidence, initial clinical picture and medical care, and three-week case fatality. Stroke 1982, 13:629-634.
37. Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. Journal of Neurology, Neurosurgery & Psychiatry 1988, 51:1373-1380.
38. Van den Hoogen HJM, Huygen FJA, Schellekens JWG, Straat JM, Van der Velden HGM. Morbidity Figures from General Practices (1978-1982). Nijmegen, University Department of General Practice 1985,
39. Dennis MS, Bamford JM, Sandercock PA, Warlow CP. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke 1989, 20:333-339.
40. Dutch TIA Trial Study Group A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991, 325:1261-1266. 10.1056/NEJM199110313251801, 1922220, Dutch TIA Trial Study Group.
41. Howard G, Evans GW, Murros KE, Toole JF, Lefkowitz D, Truscott BL. Cause specific mortality following cerebral infarction. Journal of Clinical Epidemiology 1989, 42:45-51. 10.1016/0895-4356(89)90024-3, 2913185.
42. Howard G, Walker MD, Becker C, Coull B, Feibel J, McLeroy K, Toole JF, Yatsu F. Community Hospital-based Stroke Programs: North Carolina, Oregon, and New York. III. Factors influencing survival after stroke: proportional hazards analysis of 4219 patients. Stroke 1986, 17:294-299.